News Quantified

HOTH – hoth therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Hoth Therapeutics (HOTH) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $5.00 price target on the stock.

Hoth Therapeutics Deploys OpenAI API to Advance Development of Orphan HT-KIT Oncology Program [Yahoo! Finance]

Hoth Therapeutics Deploys OpenAI API to Advance Development of Orphan HT-KIT Oncology Program

HOTH THERAPEUTICS ACCELERATES HT-001 TRIAL ENROLLMENT WITH NEW CLINICAL SITE AS PATIENT DEMAND INCREASES

Hoth Therapeutics Receives U.S. Notice of Allowance for Novel Exon-Skipping Therapy Targeting Allergic Diseases

Form 8-K Hoth Therapeutics, Inc. For: Jan 16

Form EFFECT Hoth Therapeutics, Inc.

Top News Gainers

3/23 Hoth Therapeutics Announces Agreement to Joint Development of a Self-Assembling Vaccine (SAV) for the Potential Treatment of the Coronavirus (COVID-19) 38.5%

4/22 Hoth Therapeutics to Host Shareholder Update Conference Call with Dr. Mark Poznansky to Discuss COVID-19 Vaccine Candidate, VaxCelerate 30.8%

2/4 Hoth Initiates Preclinical Gene Therapy Program with NC State for the Treatment of Asthma and Allergic Inflammation 16.0%

11/26 Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy 15.9%

6/27 Hoth Therapeutics, Inc. Enters into Sponsored Research Agreement with the George Washington University 12.8%

12/26 Form 4 Hoth Therapeutics, Inc. For: Dec 24 Filed by: Hayes Anthony 11.5%

4/24 Voltron Therapeutics, Inc. Announces Selection of the First of Two Sets of Virus Targeting Peptides for Animal Testing in the Development of a COVID-19 Vaccine 8.8%

8/23 Form 8-K Hoth Therapeutics, Inc. For: Aug 19 7.9%

6/11 Biotech Brief: Atopic Dermatitis (Eczema) Revenues Projected to Exceed $6 Billion by 2022 7.4%

4/3 Form S-1 Hoth Therapeutics, Inc. 7.3%

Top News Decliners

3/23 Hoth Therapeutics inks deal to develop vaccine for Covid-19 [Seeking Alpha] -38.3%

3/27 HaloVax™ Announces Agreement with Hoth Therapeutics to Joint Develop a Self-Assembling Vaccine (SAV) to Protect Patients at Risk of Coronavirus (COVID-19) Infection -21.8%

4/23 REMINDER: Hoth Therapeutics to Host Shareholder Update Conference Call with Dr. Mark Poznansky to Discuss COVID-19 Vaccine Candidate, VaxCelerate -19.8%

3/23 Hoth Therapeutics, Inc. Announces Proposed Public Offering of Common Stock -15.8%

7/22 Biotech Brief: Reports Forecast Continued Rise in Revenues for Diabetic Ulcer Treatment Market -14.7%

8/30 Form S-1 Hoth Therapeutics, Inc. -12.0%

3/4 Form SC 13G Hoth Therapeutics, Inc. Filed by: EITNER MATTHEW D. -8.6%

9/6 Hoth Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference and RESI 2019 Boston Conference -8.5%

10/25 Form 424B3 Hoth Therapeutics, Inc. -7.9%

3/16 Diamond Equity Research Publishes Report Valuing HOTH Common Stock at $7.00 Per Share -7.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day